Pfizer Upgraded to “Buy” at SunTrust (PFE)

By Staff,

Shutterstock photo

Pharma giant Pfizer Inc. ( PFE ) caught an upgrade on Monday from analysts at SunTrust.

The firm boosted its rating on WSM from "Neutral" to "Buy" with a $40 price target. That new target represents a massive expected upside of 130% to the stock's Friday closing price of $17.42.

Pfizer shares rose 15 cents, or +0.9%, in premarket trading Monday.

The Bottom Line
Shares of PFE have a 4.13% dividend yield, based on Friday's closing stock price of $17.42. The stock has technical support in the $15-$17 price area. If the shares can firm up, we see overhead resistance around the $19-$20 price levels. We would remain on the sidelines for now.

Pfizer Inc. ( PFE ) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by

This article appears in: Investing Stocks
Referenced Stocks: PFE

More from

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by